Concepedia

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

Vanita R. Aroda, Guillermo González-Gálvez, Randi Grøn, Natalie Halladin, Martin Haluzı́k, György Jermendy, Adri Kok, Petra Örsy, Mohamed Sabbah, Giorgio Sesti,

The Lancet Diabetes & Endocrinology · 2019 · 67 citations · 21 references

DOI

Concepts

References

21

World Medical Association Declaration of Helsinki

JAMA · 2013 · 29.4K citations

, , +2

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al. · New England Journal of Medicine · 2008 · 7.8K citations · Full text

, , +13

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

, , +17

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

, , +13

Achievement of Goals in U.S. Diabetes Care, 1999–2010

Mohammed K. Ali, Kai McKeever Bullard, Jinan Saaddine et al. · New England Journal of Medicine · 2013 · 986 citations · Full text

, , +7